Oyster Point Announces Positive Results From Phase 2b Clinical Trials for Dry Eye Disease

PRINCETON, N.J.–(BUSINESS WIRE)–October 24, 2018 – Oyster Point Pharma, Inc., today announced results from the ONSET and RAINIER studies, two separate Phase 2b clinical trials evaluating the company’s novel therapies for the treatment of Dry Eye Disease (DED). Both studies, being presented tomorrow at the Ophthalmology Innovation Summit (OIS) meeting…Read More

Read More
Skyline Construction Adds Jeff Kuhn to Board of Directors

SAN FRANCISCO, CA. (October 10, 2018) – Skyline Construction is pleased to announce the appointment of Jessica Carps, Skyline’s CFO, and Jeff Kuhn, Administrative Partner of FLG Partners, to its Board of Directors. Jessica Carps has 15 years of experience in corporate accounting and finance for national construction and manufacturing firms….Read More

Read More
Twist Biosciences Files for IPO

FLG Partner’s, Ken Chow, was Interim CFO at Twist Biosciences in late 2016 to May 2017 when the company filed their S-1 for their upcoming IPO which was announced today. Press release from Genome-Web follows: NEW YORK (GenomeWeb) – Synthetic biology firm Twist Biosciences filed for an $86.3 million initial…Read More

Read More
Coinbase: A CFO Moves from Corporate Finance to Crypto Currency

By Kevin Manne – University of Buffalo, School of Management Over the course of his career, Tim Laehy, FLG Partner and University of Buffalo graduate (BS ’84, MBA ’85), has served in the Chief Financial Officer role at eight different companies, raising more than $3 billion in capital through three…Read More

Read More
BuildDirect Installs New Executive Team

By Sean Silcoff – The Globe and Mail Three months after emerging from credit protection, Vancouver’s BuildDirect.com Technologies Inc. unveiled a new management team on Tuesday that is dominated by former Amazon.com Inc. executives. Chief technology officer Mukund Mohan, chief revenue officer Ken Stanick and chief merchandising officer Godwin Pavamani, all former…Read More

Read More